JNJ
Johnson & Johnson
Health Care
Pharmaceuticals
New Brunswick, New Jersey
Last filing: Feb 11, 2026 (FY2025)
Balance Sheet 11 Accounts • 5 Years
| Account | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| BS_Assets_ShortTermInvest | $0 | — | $4.5B | — | — |
| BS_Assets_AcctsReceivable | $0 | — | $14.9B | — | — |
| BS_Assets_Inventory | $0 | — | $11.2B | — | — |
| BS_Assets_PPE | $0 | — | $19.9B | — | — |
| BS_Assets_Goodwill | $3.5B | — | $36.6B | — | — |
| BS_Liab_AccruedLiab | $0 | — | $10.2B | — | — |
| BS_Liab_OtherNoncurrent | $0 | — | $13.4B | — | — |
| BS_Equity_PreferredStock | $0 | — | $0 | — | — |
| BS_Equity_CommonStock | $0 | — | $3.1B | — | — |
| BS_Equity_TreasuryStock | $6.0B | — | $75.7B | — | — |
| BS_Equity_AOCI | $0 | — | $-12.5B | — | — |